Overall rank by patents
#33,030
Across all tracked assignees
USPTO PatentsView assignee record - 8 granted patents across 12 technology areas, active 2021–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: B33Y (ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE ).
The verdict
Rokit holds 8 US patents across 12 technology areas, rank #33,030 of 50,000 tracked assignees.
Rokit Healthcare Inc. has been granted 8 US utility patents between 2021 and 2025, placing Rokit Healthcare Inc. at rank #33,030 across all assignees tracked by PlainPatent. This portfolio spans 12 distinct Cooperative Patent Classification (CPC) subclasses, averaging 9.9 claims per patent with primary concentration in B33Y (ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE ). As a Foreign Corporation, Rokit Healthcare Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Rokit sits between Robo3 Co., Ltd. (8 patents, rank #33,026) and Rotork Controls Limited (8 patents, rank #33,034) - the closest US assignees by grant volume. The composite Innovation Score of 45.8/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2021 through 2025, with 8 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Rokit Healthcare Inc.'s 9.9 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while concentration in 12 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Rokit Healthcare Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
ROBO3 CO., LTD.
8 patents
ROBURN COMPANY LTD.
8 patents
ROC S.r.l.
8 patents
ROEN Surgical, Inc.
8 patents
ROMAINE EMPIRE, INC.
8 patents
ROTA YOKOGAWA GMBH & CO. KG
8 patents
ROTO FRANK FENSTER—UND TUERTECHNOLOGIE GMBH
8 patents
ROTORK CONTROLS LIMITED
8 patents
ROKIT HEALTHCARE INC.
8 patents
What this shows Rokit holds 8 patents at rank #33,030, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #33,030 in granted patent volume.
Other assignees with the most granted patents in Rokit's primary technology class.
Rokit's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
46 Top 22% higher than 78% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2021 | 1 | 12.5% |
| 2023 | 2 | 25.0% |
| 2024 | 4 | 50.0% |
| 2025 | 1 | 12.5% |
Top 12 of 12 technology areas
Overall rank by patents
#33,030
Across all tracked assignees
45.8 out of 100
How to use this portfolio
Rokit's 8 grants land it in the top 22% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.